Author Correction: Inflammation across tissues: can shared cell biology help design smarter trials?
Author Correction: Inflammation across tissues: can shared cell biology help design smarter trials?
复制标题
作者更正：跨组织炎症：共享细胞生物学可以帮助设计更智能的试验吗？
DOI：
10.1038/s41584-023-01049-6
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Hosack T
中科院分区：
文献类型：
--
作者：
Hosack T
在最初发表的文章版本中，图1b中有错误。在“Axial spondylarthritis”下的IL-23的框和在“Psodium”下的CTLA-4的框被错误地显示为表示“有效”而不是“无效”的颜色，并且在“Psoriatic arthritis”和“Psodium”下的JAK的框被显示为“无效”而不是“有效”。此外，在文本的“IMID中常见和独特的治疗主题”部分，在现在阅读为“抗IL-17 A治疗对AS或PsA患者有效，但对克罗恩病患者有害”的句子中，出现“RA”而不是“AS”。这些错误已在本文的HTML和PDF版本中得到纠正。
In the version of the article initially published, there were errors in Fig. 1b. The boxes for IL-23 under “Axial spondyloarthritis” and for CTLA-4 under “Psoriasis” were mistakenly shown with the color signifying “effective” instead of “ineffective”, and the boxes for JAK under “Psoriatic arthritis” and “Psoriasis” were shown as “ineffective” instead of “effective”. Additionally, in the “Common and distinct therapeutic themes in IMIDs” section of the text, in the sentence now reading “Anti-IL-17A therapy is efficacious for patients with AS or PsA but deleterious for patients with Crohn’s disease”,“RA” appeared rather than “AS”. These errors have been corrected in the HTML and PDF versions of the article.